Literature DB >> 23644971

Fosfomycin-containing second-line treatment for Helicobacter pylori infection.

Josué Barahona-Garrido, Nery F Quiñonez, Eduardo Cerda-Contreras, Helga Maria Sarti, Félix I Téllez-Ávila.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23644971     DOI： 10.1038/ajg.2013.48

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  3 in total

Review 1.  Fosfomycin.

Authors:  Matthew E Falagas; Evridiki K Vouloumanou; George Samonis; Konstantinos Z Vardakas
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

2.  Three unsuccessful treatments of Helicobacter pylori infection by a highly virulent strain with quadruple antibiotic resistance.

Authors:  Lyudmila Boyanova; Ivailo Evstatiev; Daniel Yordanov; Rumyana Markovska; Ivan Mitov
Journal:  Folia Microbiol (Praha)       Date:  2015-12-03       Impact factor: 2.099

3.  Synergistic activity and molecular modelling of fosfomycin combinations with some antibiotics against multidrug resistant Helicobacter pylori.

Authors:  Ahmed Megahed Abouwarda; Tarek Abdelmonem Ismail; Wael Mohamed Abu El-Wafa; Ahmed Hassan Ibrahim Faraag
Journal:  World J Microbiol Biotechnol       Date:  2022-04-29       Impact factor: 4.253
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.